Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Approval Reforms Ineffective Without Payer Reforms, Tunis Argues

Executive Summary

Granting payers more conditional coverage authority may be necessary for legislation to succeed at accelerating biomedical innovation, the former CMS CMO argues, but industry may not be on board.

You may also be interested in...

The Sovaldi Anniversary? Burgess Wants Part D Milestone To Change How Gov’t Values Rx Spending

Congressional budget projections should use longer time horizons, Vice-Chair of House Energy and Commerce Health Subcommittee argues; meanwhile former FDA Commissioner suggests costly drugs could be paid for on a mortgage model.

Brand Exclusivity Increases: Incentivizing Innovation, Or Leading America To Ruin?

House Energy and Commerce’s 21st Century Cures Initiative hears arguments for why exclusivity reform is necessary, but Rep. Waxman argues that more research about its impact on drug discovery is needed first.

Where’s Upton? 21st Century Cures Take Temporary Back Seat To The Internet

Republicans dominate first official 21st Century Cures hearing, but Net Neutrality forces many members to choose, and the initiative’s leader makes quick exit.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts